Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer

详细信息    查看全文

• 作者：Mohammad R. Akbari^a ; ^b ; Laura N. Anderson^c ; Daniel D. Buchanan^d ; Mark Clendenning^d ; Mark A. Jenkins^e ; Aung Ko Win^e ; John L. Hopper^e ; Graham G. Giles^f ; Robert Nam^g ; Steven Narod^a ; ^b ; Steven Gallinger^c ; ^h ; Sean P. Cleary^c ; ^h ; ^{sean.cleary@uhn.ca}
• 关键词：CRC ; colorectal cancer ; OFCCR ; Ontario Familial Colon Cancer Family Registry ; ACCFR ; Australasian Colorectal Cancer Family Registry ; HW ; Health Watch Study ; OR ; odds ratio ; CI ; confidence interval
• 刊名：Cancer Epidemiology
• 出版年：2013
• 出版时间：August, 2013
• 年：2013
• 卷：37
• 期：4
• 页码：424-427
• 全文大小：182 K

文摘

Introduction: The HOXB13 pGly84Glu mutation has recently been associated with an increased risk of prostate cancer but the association of other cancer sites with this allele has not been assessed. Data has suggested that HOXB13 expression levels are decreased in colorectal cancer (CRC) cell lines indicating this gene may be involved in colorectal tumourigenesis. Methods: To evaluate a potential association of this mutation with CRC, we genotyped the mutation in 2695 CRC cases and 4593 controls from population-based registries in Canada and Australia. Results: The HOXB13 pGly84Glu mutation was more common in CRC cases than controls (0.48 % vs. 0.17 % , P = 0.02) indicating a significant association between the HOXB13 variant and CRC risk (OR = 2.8; 95 % CI: 1.2-6.8). This association was attenuated but remained significant with the inclusion of previously published and publicly available genotype data. Pedigree analysis of cases and controls revealed that 7/21 HOXB13 mutation carriers had a family history of prostate cancer. Discussion: This report is the first to suggest a risk of CRC associated with mutations in the HOXB13 gene. These findings require further validation but may be of importance in the screening and genetic counseling of families known to carry the HOXB13 pGly84Glu mutation.